Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The G-BA Innovation Committee recommends transfer to standard care for another three projects in Germany

On December 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for another three completed projects. Two projects evaluated the decision support tools for the BRCA1/2 mutation carriers. The third project analyzed the healthcare provided for patients with congenital heart defects.

The project “EDCP-BRCA - Evaluation of a decision coaching program for decision support in the context of prevention for BRCA1/2 mutation carriers” offered structured, modular, and needs-adapted coaching to support BRCA1/2 mutation carriers to decide between currently existing breast and ovarian cancer preventive options. Despite the limitations of the project, the Innovation Committee believes the results can improve care for women with familial cancer.

Within the project “iKNOW – Development and evaluation of an online-supported counseling tool for BRCA1/2 mutation carriers”, the guideline-based online consultation tool, iKNOW, was developed. iKNOW is aimed to support BRCA1/2 mutation carriers to assess their individual breast cancer risk.

The “OptAHF – optimizing care for children and adults with congenital heart defects” project was aimed at studying a data mix to map the reality of healthcare for patients with congenital heart defects, to highlight the identified problems, and to propose the needed actions in this regard.

The full details in German can be found here, here (decision and the results of the EDCP-BRCA project), here (decision and the results of the iKNOW project), and here (decision and the results of the OptAHF project)

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.